Unlocking The Potential Of Therapeutics For Fibrosis & Oncologynuformix Is A Pharmaceutical Development Company Targeting Unmet Medical Needs In Fibrosis And Oncology Via Drug Repurposingthe Company Aims To Use Its Expertise In Discoveringdeveloping And Patenting Novel Drug Formswith Improved Physical Propertiesto Develop New Products In New Indications That Areimportantlydifferentiated From The Originalby Way Of Dosagedelivery Route Or Presentation Thus Creating New And Attractive Commercial Opportunitiesnuformix Has An Early Stage Pipeline Of Preclinical And Phase 1 Ready Assets With Potential For Significant Value And Early Licensing Opportunities
